Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.15 - $0.37 $2,600 - $6,415
17,339 Added 59.38%
46,538 $7,000
Q1 2024

May 15, 2024

SELL
$0.19 - $0.3 $2,035 - $3,214
-10,714 Reduced 26.84%
29,199 $7,000
Q4 2023

Feb 13, 2024

SELL
$0.12 - $0.64 $817 - $4,357
-6,809 Reduced 14.57%
39,913 $8,000
Q3 2023

Nov 14, 2023

BUY
$0.12 - $0.41 $4,647 - $15,878
38,727 Added 484.39%
46,722 $6,000
Q2 2023

Aug 14, 2023

SELL
$0.35 - $0.72 $4,641 - $9,547
-13,260 Reduced 62.39%
7,995 $2,000
Q1 2023

May 09, 2023

BUY
$0.39 - $0.6 $1,959 - $3,014
5,024 Added 30.95%
21,255 $10,000
Q4 2022

Feb 10, 2023

SELL
$0.46 - $42.69 $1,434 - $133,107
-3,118 Reduced 16.11%
16,231 $8,000
Q3 2022

Nov 10, 2022

BUY
$0.63 - $33.0 $12,189 - $638,517
19,349 New
19,349 $12,000
Q2 2022

Aug 15, 2022

SELL
$0.63 - $0.96 $3,532 - $5,382
-5,607 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$0.5 - $1.06 $2,803 - $5,943
5,607 New
5,607 $5,000
Q4 2021

Feb 14, 2022

SELL
$0.92 - $1.22 $42,261 - $56,041
-45,936 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$0.67 - $1.51 $30,777 - $69,363
45,936 New
45,936 $60,000
Q2 2021

Aug 16, 2021

SELL
$0.75 - $1.1 $59,267 - $86,925
-79,023 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$0.96 - $1.74 $68,744 - $124,599
71,609 Added 965.86%
79,023 $83,000
Q4 2020

Feb 16, 2021

BUY
$0.76 - $1.47 $5,558 - $10,751
7,314 Added 7314.0%
7,414 $10,000
Q1 2020

May 15, 2020

BUY
$0.6 - $2.31 $60 - $231
100 New
100 $0
Q3 2018

Nov 13, 2018

SELL
$0.35 - $0.92 $1,935 - $5,086
-5,529 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$0.42 - $0.74 $2,322 - $4,091
5,529 New
5,529 $2,000
Q1 2018

May 15, 2018

SELL
$0.76 - $1.32 $16,097 - $27,958
-21,181 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$1.1 - $1.54 $23,290 - $32,606
21,173 Added 264662.5%
21,181 $25,000
Q3 2017

Nov 14, 2017

BUY
$1.19 - $1.43 $9 - $11
8
8 $0

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.